Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CRHBP | P24387 | 2/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4394616 | 1.00 | — | — | |
| SCHEMBL1933520 | 1.00 | LMNA (0.42) | LMNAALDH1A1TP53TSHRGAA | |
| SCHEMBL29008 | 1.00 | — | — | |
| SCHEMBL7200305 | 0.97 | GAA (0.44) | LMNAALDH1A1TP53TSHRGAA | |
| SCHEMBL6121060 | 0.97 | GAA (0.44) | LMNAALDH1A1TP53TSHRGAA | |
| Methane SCHEMBL29072799 | 0.97 | — | — | |
| SCHEMBL10985053 | 0.97 | — | — | |
| Dioxane SCHEMBL6669275 | 0.97 | GAA (0.44) | LMNAALDH1A1TP53TSHRGAA | |
| SCHEMBL1933467 | 0.97 | GAA (0.44) | LMNAALDH1A1TP53TSHRGAA | |
| SCHEMBL11522424 | 0.91 | LMNA (0.40) | LMNAALDH1A1TP53TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10501761-B2 | Processing biomass to obtain hydroxylcarboxylic acids | XYLECO, INC. (US) | 2019-12-10 | — | — | US | claimed |
| US-20160076062-A1 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. | 2016-03-17 | — | — | US | claimed |
| US-20160053047-A1 | PROCESSING BIOMASS | XYLECO, INC. | 2016-02-25 | — | — | US | claimed |
| EP-2413981-A1 | THICK FOAMS FOR BIOMEDICAL APPLICATIONS AND METHODS OF MAKING | Advanced Technologies and Regenerative Medicine, LLC (US) | 2012-02-08 | — | — | EP | claimed |
| US-20110034388-A1 | COLLAGEN AND FIBRIN MICROTHREADS IN A DISCRETE THREAD MODEL OF IN VITRO ACL SCAFFOLD REGENERATION | WORCESTER POLYTECHNIC INSTITUTE | 2011-02-10 | — | — | US | claimed |
| EP-1491156-B1 | Porous resorbable graft fixation pin | DEPUY MITEK INC (US) | 2008-12-31 | — | — | EP | claimed |
| WO-2001002033-A1 | PROCESS FOR MANUFACTURING BIOMEDICAL FOAMS | ETHICON, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| US-11612491-B2 | Zero profile spinal fusion cage | DePuy Synthes Products, Inc. (US) | 2023-03-28 | — | — | US | disclosed |
| US-20230020338-A1 | ZERO PROFILE SPINAL FUSION CAGE | DEPUY SYNTHES PRODUCTS INC (US) | 2023-01-19 | — | — | US | disclosed |
| US-20200208180-A1 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. (US) | 2020-07-02 | — | — | US | disclosed |
| US-10624758-B2 | Zero profile spinal fusion cage | DePuy Synthes Products, Inc. (US) | 2020-04-21 | — | — | US | disclosed |
| US-10501761-B2 | Processing biomass to obtain hydroxylcarboxylic acids | XYLECO, INC. (US) | 2019-12-10 | — | — | US | disclosed |
| US-20190322800-A1 | PROCESSING HYDROXY-CARBOXYLIC ACIDS TO POLYMERS | XYLECO, INC. (US) | 2019-10-24 | — | — | US | disclosed |
| US-20080311087-A1 | Human Umbilical Tissue-Derived Cell Compositions for the Treatment of Incontinence | ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC | 2008-12-18 | — | — | US | disclosed |
| US-20080102123-A1 | Self-gelling tunable drug delivery system | ENDO-SURGERY, INC. | 2008-05-01 | — | — | US | disclosed |
| US-20070270854-A1 | Bone anchoring device | LI ZHIGANG | 2007-11-22 | — | — | US | disclosed |
| US-20070213750-A1 | Composite Staple for Completing an Anastomosis | ETHICON, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| US-20060153815-A1 | Tissue engineering devices for the repair and regeneration of tissue | ETHICON, INC. | 2006-07-13 | — | — | US | disclosed |
| US-20060058834-A1 | Foam matrix embolization device | CORDIS CORPORATION | 2006-03-16 | — | — | US | disclosed |
| WO-2001002033-A1 | PROCESS FOR MANUFACTURING BIOMEDICAL FOAMS | ETHICON, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160053047-A1 | PROCESSING BIOMASS | SCD, FASN, PFAS | LMNA 1329/4885ALDH1A1 1704/4885TP53 1992/4885 |
| US-20060153815-A1 | Tissue engineering devices for the repair and regeneration of tissue | ILK, PGF, KRT18 | LMNA 1974/4885ALDH1A1 3045/4885TP53 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.